BioRestorative Therapies Inc. (BRTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioRestorative Therapies ...

    NASDAQ: BRTX · Real-Time Price · USD
    1.57
    -0.03 (-1.88%)
    At close: Sep 12, 2025, 12:38 PM

    BioRestorative Therapies Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 401K 145.8K 119.8K 46K
    Cost of Revenue
    		 28.07K 165.74K 120.54K 205.21K
    Gross Profit
    		 372.93K -19.93K 119.8K 46K
    Operating Income
    		 -11.56M -15.22M -18.97M -26.31M
    Interest Income
    		 616.08K 552.29K 11.65K n/a
    Pretax Income
    		 -8.98M -10.42M -13.22M -44.3M
    Net Income
    		 -8.98M -10.42M -13.22M -44.3M
    Selling & General & Admin
    		 6.58M 11.33M 15.58M 25.62M
    Research & Development
    		 5.35M 4.03M 3.51M 729.06K
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 11.93M 15.37M 19.09M 26.35M
    Interest Expense
    		 n/a n/a n/a 1.82M
    Selling & Marketing Expenses
    		 n/a 168.03K 163.13K 12.29K
    Cost & Expenses
    		 11.96M 15.37M 19.09M 26.35M
    Income Tax Expense
    		 n/a n/a -479.26K -14.36M
    Shares Outstanding (Basic)
    		 7.76M 4.22M 3.62M 1.19M
    Shares Outstanding (Diluted)
    		 7.76M 4.22M 3.62M 1.19M
    EPS (Basic)
    		 -1.16 -2.47 -3.65 -37.3
    EPS (Diluted)
    		 -1.16 -2.47 -3.65 -37.3
    EBITDA
    		 -11.37M -10.25M -18.85M -26.22M
    EBIT
    		 -11.56M -10.42M -18.97M -26.31M
    Depreciation & Amortization
    		 189.06K 165.74K 120.54K 205.21K

    Add to Watchlist